The Leadless AV Versus DDD Pacing Study

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 100 participants.

Also called NCT05498376

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05498376
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Switzerland (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05498376. Randomized; no masking; primary purpose treatment. Start 2022-08-23 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
The Leadless AV Versus DDD Pacing Study
Acronym
LEAVE DDD
Condition
Cardiac Pacemaker
Condition
Arrhythmias, Cardiac
Condition
Heart Diseases
Condition
Cardiovascular Diseases
Intervention (Device)
Conventional pacemaker DDD
Intervention (Device)
Leadless pacemaker Micra AV
Lead sponsor
Insel Gruppe AG, University Hospital Bern (class: other)
Collaborator
University of Bern (class: other)

Record details

Record id
cardio:ct-nct05498376
Content hash
a514a2261528942bf81c1cf5ab613ba213af721b69cffeb1cf1df80b3a657f34